Patel Amit N, Lamb Jason, Patel Nilesh, Santos Ricardo S, Stavropoulos Christos, Landreneau Rodney J
Section of Thoracic Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
Semin Thorac Cardiovasc Surg. 2003 Oct;15(4):457-63. doi: 10.1053/j.semtcvs.2003.10.001.
There remains great controversy as to the indications and true benefits for pulmonary metastasectomy. The number of metastatic lesions, length of disease-free interval, and unilaterality has shown to be important prognostic factors on overall survival. In this review, we evaluate a number of clinical trials and critically assess the rational to perform pulmonary metastasectomy, which is a local treatment for a systemic disease process.
关于肺转移瘤切除术的适应症和真正益处仍存在很大争议。转移灶数量、无病间期长短以及单侧性已被证明是影响总体生存的重要预后因素。在本综述中,我们评估了多项临床试验,并严格评估了进行肺转移瘤切除术的合理性,肺转移瘤切除术是针对全身性疾病过程的一种局部治疗方法。